{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:16:05Z","timestamp":1771049765491,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,26]]},"DOI":"10.7759\/cureus.42479","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T13:01:45Z","timestamp":1690376505000},"source":"Crossref","is-referenced-by-count":2,"title":["Implications of Caspase 1\/ Interleukin-1 Beta (IL-1\u03b2) Signaling and Hypoxia-Inducible Factor 1-Alpha (HIF-1\u03b1) on Diabetic Retinopathy Pathology"],"prefix":"10.7759","author":[{"given":"Drew","family":"Garber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2018.0019","article-title":"Diabetic retinopathy assessment variability among eye care providers in an urban teleophthalmology program","volume":"25","author":"Liu Y","year":"2019","unstructured":"Liu Y, Rajamanickam VP, Parikh RS, et al.. Diabetic retinopathy assessment variability among eye care providers in an urban teleophthalmology program. Telemed J E Health. 2019, 25:301-8. 10.1089\/tmj.2018.0019","journal-title":"Telemed J E Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.04.003","article-title":"The pathology associated with diabetic retinopathy","volume":"139","author":"Lechner J","year":"2017","unstructured":"Lechner J, O'Leary OE, Stitt AW. The pathology associated with diabetic retinopathy. Vision Res. 2017, 139:7-14. 10.1016\/j.visres.2017.04.003","journal-title":"Vision Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ins.2007.07.020","article-title":"Identification of different stages of diabetic retinopathy using retinal optical images","volume":"178","author":"Yun W","year":"2008","unstructured":"Yun W, Acharya U, Venkatesh Y, Chee C, Min LC, Ng EYK. Identification of different stages of diabetic retinopathy using retinal optical images. Info Sci. 2008, 178:106-21. 10.1016\/j.ins.2007.07.020","journal-title":"Info Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2004.06.007","article-title":"Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells","volume":"79","author":"Sall JW","year":"2004","unstructured":"Sall JW, Klisovic DD, O'Dorisio MS, Katz SE. Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells. Exp Eye Res. 2004, 79:465-76. 10.1016\/j.exer.2004.06.007","journal-title":"Exp Eye Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181679c0b","article-title":"Combination intravitreal bevacizumab\/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma","volume":"28","author":"Ehlers JP","year":"2008","unstructured":"Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab\/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. 2008, 28:696-702. 10.1097\/IAE.0b013e3181679c0b","journal-title":"Retina"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(13)38009-9","article-title":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7","volume":"98","year":"1991","unstructured":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991, 98.741-56. 10.1016\/s0161-6420(13)38009-9","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Gross JG","year":"2015","unstructured":"Gross JG, Glassman AR, Jampol LM, et al.. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015, 314:2137-46. 10.1001\/jama.2015.15217","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182115679","article-title":"The impact of pulse duration and burn grade on size of retinal photocoagulation lesion: implications for pattern density","volume":"31","author":"Palanker D","year":"2011","unstructured":"Palanker D, Lavinsky D, Blumenkranz MS, Marcellino G. The impact of pulse duration and burn grade on size of retinal photocoagulation lesion: implications for pattern density. Retina. 2011, 31:1664-9. 10.1097\/IAE.0b013e3182115679","journal-title":"Retina"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-017-0345-5","article-title":"The role of glycemic control and variability in diabetic retinopathy","volume":"9","author":"Chatziralli IP","year":"2018","unstructured":"Chatziralli IP. The role of glycemic control and variability in diabetic retinopathy. Diabetes Ther. 2018, 9:431-4. 10.1007\/s13300-017-0345-5","journal-title":"Diabetes Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007543.pub2","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"6","author":"Callaghan BC","year":"2012","unstructured":"Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012, 6:CD007543. 10.1002\/14651858.CD007543.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","article-title":"Vitrectomy surgery of diabetic retinopathy complications","volume":"60","author":"Constantin BD","year":"2016","unstructured":"Constantin BD, Andrei B, Andreea M. Vitrectomy surgery of diabetic retinopathy complications . Rom J Ophthalmol. 2016, 60:31-6.","journal-title":"Rom J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2002","article-title":"Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Sim\u00f3 R","year":"2014","unstructured":"Sim\u00f3 R, Sundstrom JM, Antonetti DA. Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care. 2014, 37:893-9. 10.2337\/dc13-2002","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12384","article-title":"New treatments for diabetic retinopathy","volume":"17","author":"Das A","year":"2015","unstructured":"Das A, Stroud S, Mehta A, Rangasamy S. New treatments for diabetic retinopathy. Diabetes Obes Metab. 2015, 17:219-30. 10.1111\/dom.12384","journal-title":"Diabetes Obes Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10347","article-title":"Methylation-dependent regulation of HIF-1\u03b1 stability restricts retinal and tumour angiogenesis","volume":"7","author":"Kim Y","year":"2016","unstructured":"Kim Y, Nam HJ, Lee J, et al.. Methylation-dependent regulation of HIF-1\u03b1 stability restricts retinal and tumour angiogenesis. Nat Commun. 2016, 7:10347. 10.1038\/ncomms10347","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(02)01321-1","article-title":"Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors","volume":"133","author":"Frank RN","year":"2002","unstructured":"Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol. 2002, 133:693-8. 10.1016\/s0002-9394(02)01321-1","journal-title":"Am J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090398","article-title":"Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy","volume":"176","author":"Kim JH","year":"2010","unstructured":"Kim JH, Kim JH, Jun HO, Yu YS, Kim KW. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am J Pathol. 2010, 176:1517-24. 10.2353\/ajpath.2010.090398","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0427","article-title":"Inhibition of caspase-1\/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia","volume":"56","author":"Vincent JA","year":"2007","unstructured":"Vincent JA, Mohr S. Inhibition of caspase-1\/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 2007, 56:224-30. 10.2337\/db06-0427","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13096","article-title":"Inhibition of HIF-1\u03b1 decreases expression of pro-inflammatory IL-6 and TNF-\u03b1 in diabetic retinopathy","volume":"95","author":"Gao X","year":"2017","unstructured":"Gao X, Li Y, Wang H, Li C, Ding J. Inhibition of HIF-1\u03b1 decreases expression of pro-inflammatory IL-6 and TNF-\u03b1 in diabetic retinopathy. Acta Ophthalmol. 2017, 95:e746-50. 10.1111\/aos.13096","journal-title":"Acta Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgr034","article-title":"Src activates HIF-1\u03b1 not through direct phosphorylation of HIF-1\u03b1 specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase\/Rac pathway","volume":"32","author":"Lee HY","year":"2011","unstructured":"Lee HY, Lee T, Lee N, et al.. Src activates HIF-1\u03b1 not through direct phosphorylation of HIF-1\u03b1 specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase\/Rac pathway. Carcinogenesis. 2011, 32:703-12. 10.1093\/carcin\/bgr034","journal-title":"Carcinogenesis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2015.1006372","article-title":"Increased O-GlcNAcylation of NF-\u03baB enhances retinal ganglion cell death in streptozotocin-induced diabetic retinopathy","volume":"41","author":"Kim SJ","year":"2016","unstructured":"Kim SJ, Yoo WS, Choi M, Chung I, Yoo JM, Choi WS. Increased O-GlcNAcylation of NF-\u03baB enhances retinal ganglion cell death in streptozotocin-induced diabetic retinopathy. Curr Eye Res. 2016, 41:249-57. 10.3109\/02713683.2015.1006372","journal-title":"Curr Eye Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2005-6-2-209","article-title":"The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease","volume":"6","author":"Holmes DI","year":"2005","unstructured":"Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005, 6:209. 10.1186\/gb-2005-6-2-209","journal-title":"Genome Biol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-0989-9","article-title":"Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy","volume":"51","author":"Sim\u00f3 R","year":"2008","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia. 2008, 51:1574-80. 10.1007\/s00125-008-0989-9","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1420","article-title":"M\u00fcller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage","volume":"59","author":"Wang J","year":"2010","unstructured":"Wang J, Xu X, Elliott MH, Zhu M, Le YZ. M\u00fcller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 2010, 59:2297-305. 10.2337\/db09-1420","journal-title":"Diabetes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0707fje","article-title":"Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression","volume":"16","author":"Joussen AM","year":"2002","unstructured":"Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, D\u00f6hmen S, Adamis AP. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002, 16:438-40. 10.1096\/fj.01-0707fje","journal-title":"FASEB J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-3694","article-title":"Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy","volume":"50","author":"Abhary S","year":"2009","unstructured":"Abhary S, Burdon KP, Gupta A, Lake S, Selva D, Petrovsky N, Craig JE. Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009, 50:5552-8. 10.1167\/iovs.09-3694","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2012.01.009","article-title":"The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients","volume":"23","author":"Cosson E","year":"2013","unstructured":"Cosson E, Nguyen MT, Chanu B, Balta S, Takbou K, Valensi P. The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2013, 23:557-65. 10.1016\/j.numecd.2012.01.009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2011.11.004","article-title":"Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy","volume":"26","author":"Ola MS","year":"2012","unstructured":"Ola MS, Nawaz MI, Siddiquei MM, Al-Amro S, Abu El-Asrar AM. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications. 2012, 26:56-64. 10.1016\/j.jdiacomp.2011.11.004","journal-title":"J Diabetes Complications"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.02.034","article-title":"Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections","volume":"125","author":"Obeid A","year":"2018","unstructured":"Obeid A, Gao X, Ali FS, et al.. Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections. Ophthalmology. 2018, 125:1386-92. 10.1016\/j.ophtha.2018.02.034","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2016.63132","article-title":"The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy","volume":"41","author":"Po\u017carowska D","year":"2016","unstructured":"Po\u017carowska D, Po\u017carowski P. The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy. Cent Eur J Immunol. 2016, 41:311-6. 10.5114\/ceji.2016.63132","journal-title":"Cent Eur J Immunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.07.027","article-title":"Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor","volume":"126","author":"Obeid A","year":"2019","unstructured":"Obeid A, Su D, Patel SN, et al.. Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 2019, 126:407-13. 10.1016\/j.ophtha.2018.07.027","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-1473","article-title":"Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway","volume":"48","author":"Nagai N","year":"2007","unstructured":"Nagai N, Izumi-Nagai K, Oike Y, et al.. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci. 2007, 48:4342-50. 10.1167\/iovs.06-1473","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-008-9090-4","article-title":"Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives","volume":"9","author":"Madsen-Bouterse SA","year":"2008","unstructured":"Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008, 9:315-27. 10.1007\/s11154-008-9090-4","journal-title":"Rev Endocr Metab Disord"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru RA","year":"2007","unstructured":"Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007, 2007:43603. 10.1155\/2007\/43603","journal-title":"Exp Diabetes Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2016.01.028","article-title":"Lipid peroxidation is associated with poor control of type-2 diabetes mellitus","volume":"10","author":"Fatani SH","year":"2016","unstructured":"Fatani SH, Babakr AT, NourEldin EM, Almarzouki AA. Lipid peroxidation is associated with poor control of type-2 diabetes mellitus. Diabetes Metab Syndr. 2016, 10:S64-7. 10.1016\/j.dsx.2016.01.028","journal-title":"Diabetes Metab Syndr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-023-00314-8","article-title":"Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation","volume":"14","author":"Kropp M","year":"2023","unstructured":"Kropp M, Golubnitschaja O, Mazurakova A, et al.. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023, 14:21-42. 10.1007\/s13167-023-00314-8","journal-title":"EPMA J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2019.04.012","article-title":"Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats","volume":"195","author":"Dong Y","year":"2019","unstructured":"Dong Y, Wan G, Yan P, Qian C, Li F, Peng G. Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats. J Photochem Photobiol B. 2019, 195:51-7. 10.1016\/j.jphotobiol.2019.04.012","journal-title":"J Photochem Photobiol B"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/790902","article-title":"Hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy","volume":"2014","author":"Rajamani U","year":"2014","unstructured":"Rajamani U, Jialal I. Hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy. J Diabetes Res. 2014, 2014:790902. 10.1155\/2014\/790902","journal-title":"J Diabetes Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164837-implications-of-caspase-1-interleukin-1-beta-il-1-signaling-and-hypoxia-inducible-factor-1-alpha-hif-1-on-diabetic-retinopathy-pathology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:20Z","timestamp":1707508940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164837-implications-of-caspase-1-interleukin-1-beta-il-1-signaling-and-hypoxia-inducible-factor-1-alpha-hif-1-on-diabetic-retinopathy-pathology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.42479","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,26]]}}}